Ross is Strategic Advisor at Osmind. He is a seasoned executive with extensive experience across life sciences, health technology, medical devices, and pharma services. Ross is currently CFO at SOPHiA GENETICS, a company that democratizes data-driven medicine to improve health outcomes worldwide. Ross took SOPHiA public through an IPO in 2021. He was previously CFO and COO at Click Therapeutics, where he negotiated a $500M deal with Boehringer Ingelheim and a $300M deal with Otsuka to transform medicine through digital therapeutics. He was also previously Senior Managing Director and Partner, Equity Research at Evercore and Managing Director, Equity Research at Deutsche Bank.